Key result
Rotavirus serotype G9 constituted 27% of all rotaviruses identified in children with diarrhea in Libya, Kenya, and Cuba.
Cross-Sectional
Yes
The detection of rotavirus serotype G9 in Libya, Kenya, and Cuba emphasizes its reemergence and suggests future vaccines should protect against it.
May inform rotavirus vaccine strain selection; extends geographic surveillance data but remains hypothesis-generating.
Serotype G9 may be the fifth most common human rotavirus serotype, after serotypes G1 to G4. In three cross-sectional studies of childhood diarrhea, we have detected serotype G9 rotaviruses for the first time in Libya, Kenya, and Cuba. Serotype G9 constituted 27% of all rotaviruses identified, emphasizing the reemergence of serotype G9 and suggesting that future human rotavirus vaccines will need to protect against disease caused by this serotype.
No takes yet. Share an insight, caveat, or question.
Nigel A. Cunliffe (2001) conducted a cross-sectional in Childhood diarrhea. Rotavirus Serotype G9 was evaluated on Proportion of rotaviruses identified as Serotype G9. Rotavirus serotype G9 constituted 27% of all rotaviruses identified in children with diarrhea in Libya, Kenya, and Cuba.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: